4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-13-001340
President of R&D and CMO gave up 6,919 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Youssoufian Hagop President of R&D and CMO | 2012-12-31 | Shares withheld for taxes | −6,919 | $4.21 | $29,129 | 92,721 | D |
| Derivatives | |||||||
| Youssoufian Hagop President of R&D and CMO | 2012-12-31 | Grant or award · Employee Stock Option (right to buy) | +180,000 | 180,000 | D | ||
Loading xslF345X03/doc4.xml…